This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral molecules. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) that target specific biological pathways. Its chiral structure makes it valuable in creating enantiomerically pure drugs, which are critical for ensuring efficacy and reducing side effects. Additionally, it is employed in the study of enzyme inhibition and receptor binding due to its unique trifluoroethyl group, which can enhance binding affinity and metabolic stability. Researchers also explore its potential in designing drugs for central nervous system disorders, leveraging its ability to cross the blood-brain barrier.